Global Map > Startups > North America > United States > Louisville > ApoVax, Inc.
ApoVax, Inc. icon
ApoVax, Inc. is based on the work of Haval Shirwan, Ph.D. at the University of Louisville. ApoVax104, an immunostimulatory adjuvant construct, consists of streptavidin fused to the costimulatory molecule 4-1BBL. It is well differentiated from other adjuvants. ApoVax104 can be mixed with or conjugated to any biotinylated antigen (or peptide)--cancer or infectious disease. ApoVax is also developing ApoFasL—a means of immunomodulation for tolerance induction—for the treatment of Type 1 diabetes.
Rankings by SemRush
National Ranking
14171st
in United States
Regional Ranking
15350th
in North America
Global Ranking
32097th
worldwide
Loading startups...
Need more insights about local startups?
See more with PRO